Risk factors for CMV infection among adults with RMDs included diabetes, prior malignancy, IV cyclophosphamide, and initial prednisolone >0.91 mg/kg/day.

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully completed recruitment for its first-in-human Phase I ...

QIMR Berghofer biotechnology spin-out company, Cyteph Pty Ltd , has successfully completed recruitment for its first-in-human ...